Home > National Drug Code (NDC) > Tekturna HCT

Tekturna HCT - 0078-0521-15 - (aliskiren hemifumarate and hydrochlorothiazide)

Alphabetical Index


Drug Information of Tekturna HCT

Product NDC: 0078-0521
Proprietary Name: Tekturna HCT
Non Proprietary Name: aliskiren hemifumarate and hydrochlorothiazide
Active Ingredient(s): 150; 12.5    mg/1; mg/1 & nbsp;   aliskiren hemifumarate and hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Tekturna HCT

Product NDC: 0078-0521
Labeler Name: Novartis Pharmaceuticals Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022107
Marketing Category: NDA
Start Marketing Date: 20080801

Package Information of Tekturna HCT

Package NDC: 0078-0521-15
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (0078-0521-15)

NDC Information of Tekturna HCT

NDC Code 0078-0521-15
Proprietary Name Tekturna HCT
Package Description 30 TABLET, FILM COATED in 1 BOTTLE (0078-0521-15)
Product NDC 0078-0521
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name aliskiren hemifumarate and hydrochlorothiazide
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20080801
Marketing Category Name NDA
Labeler Name Novartis Pharmaceuticals Corporation
Substance Name ALISKIREN HEMIFUMARATE; HYDROCHLOROTHIAZIDE
Strength Number 150; 12.5
Strength Unit mg/1; mg/1
Pharmaceutical Classes Renin Inhibitor [EPC],Renin Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Tekturna HCT


General Information